Log In
BCIQ
Print this Print this
 

ronopterin (VAS203)

  Manage Alerts
Collapse Summary General Information
Company vasopharm GmbH
DescriptionAllosteric nitric oxide (NO) synthase inhibitor
Molecular Target Nitric oxide (NO) synthase
Mechanism of ActionNitric oxide (NO) synthase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationShock / trauma
Indication DetailsTreat traumatic brain injury (TBI)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today